St. Gilgen, Austria

Albert Winfried

This inventor holds 1 USPTO granted patent. Top assignee: Adnagen Gmbh. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Albert Winfried. Retrieved from https://idiyas.com/inventor/albert-winfried

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Albert Winfried

Introduction

Albert Winfried is a notable inventor based in St. Gilgen, Austria. He has made significant strides in the field of cancer research, particularly in the detection of tumor stem cells. His work is crucial for advancing diagnostic methods in oncology.

Latest Patents

Winfried holds a patent for the invention titled "Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients." This innovative method involves selecting or enriching predetermined cells from a sample, which is then contacted with a solid surface for preferential binding. The process includes a washing step to remove the sample from the solid surface. Notably, the method incorporates a polyol during the contacting and washing steps, enhancing the detection of specific markers associated with tumor stem cells and tumor cells in epithelial-mesenchymal transition. He has 1 patent to his name.

Career Highlights

Winfried is affiliated with Adnagen GmbH, where he applies his expertise in cancer diagnostics. His work at the company has contributed to the development of innovative solutions for detecting cancer-related cells in patients.

Collaborations

Winfried collaborates with Siegfried Hauch, leveraging their combined expertise to advance research in cancer detection and treatment.

Conclusion

Albert Winfried's contributions to cancer research through his innovative patent demonstrate his commitment to improving diagnostic methods for cancer patients. His work continues to pave the way for advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…